Elan and Anglo lead market higher
Elan and Anglo Irish Bank led the rise.
Elan rose 38c to €5.81, following reports in the New England Journal of Medicine that a patient who died after taking Tysabri showed signs of the fatal infection PML, in blood samples taken months earlier.
Anglo Irish Bank saw over 4.3 million shares change hands, and added 21c to €10.18. Bank of Ireland followed suit, gaining 6c while AIB was steady at €16.90.
United Drug was unchanged at €3.47.
Other movers included CRH, gaining 12c, while Jurys Doyle slipped 15c to €14.95.






